Biotech marketing agency, built for HCP demand
Demand generation for biotech teams commercializing without a large field force.
Teams that start market preparation 18 to 24 months before approval see roughly 40% higher peak sales (Guidehouse). At that point, most biotechs have one to five commercial hires in place.
We build the specialist awareness and demand a lean team cannot build alone.
Compliantly, on both sides of the approval line.
Most agencies talk about HCP marketing HCP Compass delivers verified HCP pipeline
Life-science commercial
teams that trust us
with their HCP pipeline
24 biotech, medtech, and pharma teams have started an engagement with us.
Senior operators run every account end-to-end
Why biotech marketing agencies
miss the launch window
You have the science, but not the demand. Three reasons the model breaks.
Built for investors, not prescribers.
Biotech agencies polish pitch decks and preclinical stories. Launch success is decided by clinicians who have never heard of your asset.
Scientific dilution.
Generalist copywriters flatten your mechanism into marketing language. Your medical team rewrites everything, and timelines slip.
Pre-approval rules learned late.
Promoting an investigational product misbrands it under 21 CFR 312.7. An agency that learns this on your account creates risk, not demand.
Built for HCP demand across
biotech, medtech, and pharma
Six capabilities. From the brief to the verified prescriber in your CRM, every stage
runs through senior life-science marketing specialists.
Custom HCP marketing strategy
Discovery first, tactics second.
The Compass Method begins with deep audience and brand understanding before any channel gets configured.
MLR-ready content production
Compliance built into the brief, not added at the end.
Pre-cleared claim libraries. On-PI language. Fair-balance as a layout requirement.
Multi-channel surround
Seven channels, one MLR-cleared narrative.
LinkedIn, Doximity, Sermo, Meta, YouTube, curated Google Display, and email.
Verified lead generation
Every lead registry-verified at delivery.
NPPES (US). GMC, NMC, GPhC (UK). RPPS, LANR, BIG-register (EU).
CRM integration
Native push with verification metadata.
Veeva, Salesforce Health Cloud, or HubSpot.
AI search visibility
Cited by ChatGPT, Claude, and Perplexity.
HCPs research products on AI before the first sales call. We optimize for the AI citation layer.
The HCP social media: leverage channels, on cleared
narrative, four to six touchpoints a week.
The same cardiologist scrolls LinkedIn at 7am, checks Doximity at 8am, sees an Instagram ad at
lunch, watches a YouTube clinical talk in the evening. By Friday, your brand is one they recognise.
From discovery
to verified pipeline
Every engagement runs through a four-stage methodology. Understanding first. Strategy from understanding. Tactics from strategy. Verification at delivery.
Strategy
Deep audience discovery, brand context, and CRM planning. Journey mapped across channels. KPIs locked. Two-week sprint.
Create
MLR-ready content built from day one. Pre-cleared claim libraries. On-PI language. Fair-balance designed into the layout. Most assets clear MLR on first submission.
Activate
Multi-channel campaign launch by senior channel specialists. LinkedIn, Doximity, Sermo, Meta, YouTube, curated Google Display. No junior staff on channel configuration.
Convert and Verify
Every lead registry-checked at the moment of delivery. NPI, GMC, RPPS, LANR, BIG-register. Verification metadata travels with the lead into your CRM.
Frequently Asked Questions
It builds commercial demand for biotech companies. HCP Compass does the version most agencies skip: digital campaigns aimed at the healthcare professionals who will prescribe or recommend your product, from pre-launch awareness through verified pipeline after approval.
Not promotionally: representing an investigational drug as safe or effective misbrands it under 21 CFR 312.7. What works pre-approval is the permitted lane: scientific exchange, unbranded disease education, congress presence, and payer-directed information exchange. We build inside that lane.
Earlier than most teams plan: analysis links 18 to 24 months of pre-launch market preparation to roughly 40% higher peak sales (Guidehouse). The specialty needs to know the disease conversation, and your name in it, before your first rep call.
That is the design case. Pre-revenue biotechs typically run one to five permanent commercial hires, and we operate as the demand-generation arm around them: strategy, content, channels, and verification, coordinated with your medical and regulatory leads.
We do not publish a flat price because scope drives cost. Engagements start at $3,000 per month and scale with scope, with media budget separate. The consultation defines what your launch stage needs first.
Against the stage you are in. Pre-approval, that means specialty awareness and education engagement. Post-approval, it means cost per qualified lead with registry verification. Either way, metrics your board can read.
Arjun Shailly
CEO · HCP Compass
Ready to build verified pipeline
Speak with an HCP marketing specialist, not a salesperson
In our call, you will leave with clarity on:
- The content strategy that fits your specialty and commercial stage
- How to distribute that content precisely to the right HCPs
- The channels that actually map to your goals, not a generic list
- What it really takes to ship a campaign launch that converts
No pitch deck. No demos. Just the diagnostic conversation that decides whether the engagement is a fit.
The HCP marketing field guide
Four deeper guides across HCP demand generation, compliance, and measurement. Practitioner-direct, for the people who own the budget.
What Is HCP Targeted Marketing? How It Works in 2026
What is HCP targeted marketing? Every word in the definition is doing work. Take it apart and the discipline becomes vis…
HCP Marketing Best Practices: What Works in 2026
Here is the gap this post exists to close. In Deloitte’s March 2025 global survey, 82% of life science executives said…
Modular Content in Pharma: Build Once, Reuse Right
Here is the uncomfortable starting point. Most teams buy modular content to produce more assets, faster. Yet Veeva’s a…
